You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

temozolomide

Showing 26 - 50 of 556
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Columbus

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Natural Killer Cell Therapy
  • Temozolomide
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 28, 2022

Primary Brain Tumor, Brain Tumor, Recurrent Trial in Durham (Fluoxetine, Temozolomide)

Not yet recruiting
  • Primary Brain Tumor
  • Brain Tumor, Recurrent
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke University
Dec 20, 2022

Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid System Tumor, Metastatic Malignant Solid Tumor Trial (Biopsy,

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +5 more
  • (no location specified)
Jan 18, 2023

Glioblastoma, IDH-wildtype Trial in France, Italy (Metformin, Radiation IMRT, Temozolomide)

Not yet recruiting
  • Glioblastoma, IDH-wildtype
  • Suresnes, Hauts De Seine, France
  • +5 more
Aug 2, 2022

Solid Tumors, Neuroblastoma, Rhabdomyosarcoma Trial in Durham, Cincinnati (VAL-413, Temozolomide)

Recruiting
  • Solid Tumors
  • +5 more
  • Durham, North Carolina
  • +2 more
Jan 31, 2023

Neuroblastoma Trial (Topotecan, Temozolomide, Ribociclib)

Not yet recruiting
  • Neuroblastoma
  • (no location specified)
Jun 17, 2022

Glioblastoma, Newly Diagnosed Glioblastoma Trial in Stanford (device, drug, radiation)

Recruiting
  • Glioblastoma
  • Newly Diagnosed Glioblastoma
  • Optune
  • +3 more
  • Stanford, California
    Stanford University
Aug 1, 2022

Advanced Solid Tumor, Platinum-Resistant Ovarian Cancer, Platinum-Resistant Urothelial Carcinoma Trial in Darlinghurst, Kogarah,

Terminated
  • Advanced Solid Tumor
  • +3 more
  • Darlinghurst, New South Wales, Australia
  • +1 more
Dec 18, 2022

MGMT-Methylated Glioblastoma, Recurrent Glioblastoma, IDH-Wildtype Trial (Selinexor, Temozolomide)

Not yet recruiting
  • MGMT-Methylated Glioblastoma
  • Recurrent Glioblastoma, IDH-Wildtype
  • (no location specified)
Jun 28, 2022

Brain Tumor, Recurrent, Brain Tumor, Pediatric, CNS Tumors Trial in Houston (RRx-001, Temozolomide, Irinotecan)

Recruiting
  • Brain Tumor, Recurrent
  • +3 more
  • Houston, Texas
    Texas Children's Cancer Center
Aug 15, 2022

Malignant Glioma Trial in Nashville (Bevacizumab, Temozolomide, Vitamin C)

Completed
  • Malignant Glioma
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Mar 9, 2022

Glioblastoma, Recurrent Glioblastoma, GBM Trial in Boston (MN-166, Temozolomide)

Active, not recruiting
  • Glioblastoma
  • +3 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Nov 16, 2022

Glioblastoma Trial in Boston (radiation, biological, drug)

Recruiting
  • Glioblastoma
  • Radiation Therapy
  • +3 more
  • Boston, Massachusetts
  • +1 more
May 31, 2022

Glioblastoma Multiforme Trial in Australia, United States (Nivolumab, Temozolomide)

Active, not recruiting
  • Glioblastoma Multiforme
  • Durham, North Carolina
  • +19 more
Jul 14, 2022

Newly Diagnosed Glioblastoma Trial ([177Lu]Lu-NeoB, [68Ga]Ga-NeoB, Temozolomide)

Not yet recruiting
  • Newly Diagnosed Glioblastoma
  • (no location specified)
Feb 13, 2023

Metastatic Cancer, Unspecified Adult Solid Tumor Trial in Los Angeles (PARP inhibitor BMN-673, temozolomide, irinotecan HCl)

Completed
  • Metastatic Cancer
  • Unspecified Adult Solid Tumor
  • PARP inhibitor BMN-673
  • +4 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center
Sep 22, 2022

Recurrent Extensive Stage Small Cell Lung Carcinoma, Refractory Extensive Stage Small Cell Lung Carcinoma Trial in United States

Active, not recruiting
  • Recurrent Extensive Stage Small Cell Lung Carcinoma
  • Refractory Extensive Stage Small Cell Lung Carcinoma
  • Bakersfield, California
  • +5 more
Jan 5, 2023

Glioblastoma Trial in Zürich (Onfekafusp alfa, Temozolomide)

Recruiting
  • Glioblastoma
  • Onfekafusp alfa
  • Temozolomide
  • Zürich, Switzerland
    UniversitatSpital USZ
Apr 7, 2022

Glioblastoma Trial in France (Polysiloxane Gd-Chelates based nanoparticles (AGuIX), radiotherapy, Temozolomide)

Recruiting
  • Glioblastoma
  • Polysiloxane Gd-Chelates based nanoparticles (AGuIX)
  • +2 more
  • Brest, France
  • +5 more
Jun 16, 2022

Glioblastoma, Gliosarcoma Trial in Houston (drug, radiation, procedure)

Recruiting
  • Glioblastoma
  • Gliosarcoma
  • Houston, Texas
    M D Anderson Cancer Center
Sep 27, 2022

Malignant Glioma of Brain Trial in Chicago (Acetazolamide, Temozolomide)

Recruiting
  • Malignant Glioma of Brain
  • Chicago, Illinois
    University of Chicago Medical Center
Apr 1, 2022

Gliosarcoma, Newly Diagnosed, Glioblastoma Trial run by the National Cancer Institute (NCI) (Selinexor, Temozolomide, Generic

Recruiting
  • Gliosarcoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 7, 2022

Refractory Solid Tumors Trial in Houston (Eribulin, Irinotecan, Temozolomide)

Recruiting
  • Refractory Solid Tumors
  • Houston, Texas
    M D Anderson Cancer Center
Aug 22, 2023

Glioblastoma Trial in New York, Calgary, Toronto (BBI608, Temozolomide)

Completed
Has Results
  • Glioblastoma
  • New York, New York
  • +2 more
Apr 4, 2022

Glioblastoma, Recurrent Glioblastoma Trial in Boston (Pembrolizumab, Olaparib, Temozolomide)

Not yet recruiting
  • Glioblastoma
  • Recurrent Glioblastoma
  • Boston, Massachusetts
  • +2 more
Jul 14, 2022